PHARMACOVIGILANCE GUIDELINES

被引：0
|
作者：
LEWIS, S
机构：
来源：
LANCET | 1994年 / 343卷 / 8896期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：535 / 535
页数：1
相关论文
共 50 条
  • [41] Pharmacovigilance in Poland
    Czarnecki, A
    Maciejczyk, A
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 1997, 6 (04) : 277 - 281
  • [42] Pharmacovigilance in oncology
    Paolo Baldo
    Giulia Fornasier
    Laura Ciolfi
    Ivana Sartor
    Sara Francescon
    International Journal of Clinical Pharmacy, 2018, 40 : 832 - 841
  • [43] PEDIATRIC PHARMACOVIGILANCE
    AUTRET, E
    JONVILLE, AP
    PEDIATRIE, 1990, 45 (11): : 763 - 767
  • [44] The need for pharmacovigilance
    Olsson, S
    PHARMACOLOGY AND THERAPEUTICS IN THE NEW MILLENNIUM, 2001, : 502 - 508
  • [45] Pharmacovigilance is … Vigilance
    I. Ralph Edwards
    Rachida Soulayamani Bencheikh
    Drug Safety, 2016, 39 : 281 - 285
  • [46] Pharmacovigilance in Asia
    Biswas, Pipasha
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2013, 4 (05) : S7 - S19
  • [47] Quality in pharmacovigilance
    Edwards, Brian
    Priem, Jeffrey
    Pharmaceutical Technology North America, 2002, 26 (11): : 98 - 106
  • [48] PHARMACOVIGILANCE IN SPAIN
    LAPORTE, JR
    THERAPIE, 1987, 42 (01): : 63 - 64
  • [49] NOTE OF PHARMACOVIGILANCE
    GROSSHANS, E
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1994, 121 (09): : 673 - 676
  • [50] EC PHARMACOVIGILANCE
    LEWIS, S
    LANCET, 1993, 341 (8848): : 820 - 820
12345